During the last session, Artiva Biotherapeutics Inc (NASDAQ:ARTV)’s traded shares were 0.82 million, with the beta value of the company hitting 2.25. At the end of the trading day, the stock’s price was $2.04, reflecting an intraday gain of 13.97% or $0.25. The 52-week high for the ARTV share is $17.31, that puts it down -748.53 from that peak though still a striking 27.94% gain since the share price plummeted to a 52-week low of $1.47. The company’s market capitalization is $49.70M, and the average intraday trading volume over the past 10 days was 0.5 million shares, and the average trade volume was 222.08K shares over the past three months.
Artiva Biotherapeutics Inc (NASDAQ:ARTV) trade information
Artiva Biotherapeutics Inc (ARTV) registered a 13.97% upside in the last session and has traded in the green over the past 5 sessions. The stock spiked 13.97% in intraday trading to $2.04, hitting a weekly high. The stock’s 5-day price performance is 26.71%, and it has moved by -1.92% in 30 days. Based on these gigs, the overall price performance for the year is -79.76%. The short interest in Artiva Biotherapeutics Inc (NASDAQ:ARTV) is 1.24 million shares and it means that shorts have 9.9 day(s) to cover.
The consensus price target of analysts on Wall Street is $20.5, which implies an increase of 90.05% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $18 and $23 respectively. As a result, ARTV is trading at a discount of -1027.45% off the target high and -782.35% off the low.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings shrunk an estimated -64.01%. While earnings are projected to return 43.44% in 2025, the next five years will return 23.59% per annum.
ARTV Dividends
Artiva Biotherapeutics Inc is due to release its next quarterly earnings on 2025-May-08. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
Artiva Biotherapeutics Inc (NASDAQ:ARTV)’s Major holders
Artiva Biotherapeutics Inc insiders own 19.99% of total outstanding shares while institutional holders control 89.73%, with the float percentage being 112.15%.
Also, the Mutual Funds coming in first place with the largest holdings of Artiva Biotherapeutics Inc (ARTV) shares are SMALLCAP WORLD FUND INC and VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund . Data provided on Mar 31, 2025 indicates that SMALLCAP WORLD FUND INC owns about 866.62 shares. This amounts to just over 3.56 percent of the company’s overall shares, with a $1.77 million market value. The same data shows that the other fund manager holds slightly less at 508.3, or about 2.09% of the stock, which is worth about $1.04 million.
